Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section

NCT07908771 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-11
Last updated
2026-11-02

Condition(s) studied

AnxietyCesarean SectionBirth Satisfaction

Investigational drug(s) / intervention(s)

Virtual Reality Distraction

Virtual Reality Distraction: Participants in the intervention group will receive a standardized immersive virtual reality (VR) session via a head-mounted display with headphones during elective cesarean section under spinal anesthesia, in addition to routine care. The VR headset will be applied after adequate spinal block is confirmed. Content is a 360-degree nature video (forest, water and wildlife scenes) with natural sounds, without speech or guided meditation, lasting about 20-30 minutes and restarted if surgery lasts longer. VR will be paused at the birth of the baby for the intraoperative Face Anxiety Scale assessment and the first mother-infant contact, then resumed until the end of surgery. Volume and fit will be adjusted for comfort. VR will be stopped immediately if dizziness, nausea, headache or other discomfort occurs, or if clinically required.

Study summary

This study will examine whether virtual reality during planned cesarean birth reduces women's anxiety and improves their satisfaction with the birth experience.

The study will include 144 women undergoing elective cesarean section under spinal anesthesia at Adana City Training and Research Hospital in Türkiye. Participants will be randomly assigned to one of two groups. One group will receive routine care and watch a relaxing nature video with natural sounds through a virtual reality headset during surgery. The other group will receive routine care alone.

Virtual reality will be paused when the baby is born so that anxiety can be assessed and the mother can see her baby. It will then resume until surgery ends.

Anxiety and vital signs will be assessed before surgery and 15-30 minutes after completion of surgery, once the participant is clinically stable. An additional brief anxiety assessment will be performed immediately after birth, before the mother first sees her baby. Satisfaction with cesarean birth will be assessed 6-8 hours after birth.

The researchers will compare the results between the two groups to evaluate the effects of virtual reality on maternal anxiety and cesarean birth satisfaction.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Women scheduled for elective cesarean section * Singleton pregnancy * Term pregnancy (≥37 weeks of gestation) * Cesarean section planned under spinal anesthesia * Aged 18 years or older * Able to read, write and communicate in Turkish * Voluntary participation and written informed consent Exclusion Criteria: * Intrauterine fetal death * Major fetal congenital anomaly * Failed spinal anesthesia requiring conversion to general anesthesia, or planned general anesthesia * Visual or hearing impairment preventing use of virtual reality * History of epilepsy, vertigo or motion sickness * Diagnosed psychiatric disorder or regular use of anxiolytic/antidepressant medication

Primary outcome measure(s)

  • State Anxiety — Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
    State anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-I), Turkish version. Scores range from 20 to 80; higher scores indicate higher anxiety levels.

Trial sites (1)

FacilityCityRegionStatus
Adana City Training and Research Hospital Adana Adana
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07908771 on ClinicalTrials.gov ↗ ← All trials in Turkey